• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:燕翔,贾利影,李若楠,薛妍,王宏,赵京霞,彭冰.基于UPLC-MS、网络药理学和斑马鱼模型的白蓼花抗炎机制和活性成分研究[J].药学研究,2026,45(6):618-629[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1120次   下载 634次 本文二维码信息
码上扫一扫!
基于UPLC-MS、网络药理学和斑马鱼模型的白蓼花抗炎机制和活性成分研究
燕翔1,2,贾利影1,2,李若楠1,薛妍1,2,王宏1,2,赵京霞1,2,彭冰1,2
字体:加大+|默认|缩小-
(1.首都医科大学附属北京中医医院,北京 100010;2.北京市中医药研究所,北京 100010)
摘要:
目的 目前尚没有文献报道白蓼花活性成分和抗炎作用,本研究基于超高效液相色谱-质谱联用技术(UPLC-MS)、斑马鱼模型以及体外实验(RAW264.7小鼠单核巨噬细胞白血病细胞模型),多维度探究白蓼花的抗炎活性成分和作用机制。方法 对鲜白蓼花进行提取,得到白蓼花总提取物,采用超高效液相色谱-质谱联用技术(UPLC-MS)对白蓼花总提取物进行成分鉴别,通过体外建立脂多糖(LPS)诱导RAW264.7巨噬细胞模型,采用CCK-8法检测不同浓度白蓼花提取物处理的巨噬细胞存活率,酶联免疫吸附法 (ELISA)法检测白蓼花提取物处理巨噬细胞分泌炎性因子白细胞介素-1β(IL-1β)、IL-6、肿瘤坏死因子α(TNF-α)的水平变化,并建立斑马鱼断尾诱导的机械损伤炎症,用荧光显微观察斑马鱼皮肤中性粒细胞募集情况,评价白蓼花提取物对斑马鱼炎症模型的作用。最后通过网络药理学对白蓼花有效成分的抗炎机制进行预测分析。结果 UPLC-MS分析鉴定白蓼花总提取物含有32种成分,主要包括黄酮及其衍生物类成分,如槲皮素、芦丁、山柰酚及其苷类等,此外还含有酚酸类、核苷类、氨基酸类、萜类、有机酸类等。细胞实验结果显示,6.25 μg·mL-1白蓼花提取物对正常巨噬细胞及脂多糖(LPS)诱导的巨噬细胞均有明显的抑制作用,用白蓼花提取物处理24 h后,巨噬细胞中的IL-1β、IL-6、TNF-α的表达量均降低(P<0.05,P<0.01,P<0.001),斑马鱼实验结果显示,与正常对照组相比,模型组斑马鱼背部和腹部皮肤中性粒细胞数量增加(P<0.001),表现出明显的中性粒细胞迁移,经白蓼花提取物处理后,能抑制中性粒细胞迁移,且呈剂量依赖性。结论 白蓼花提取物通过抑制巨噬细胞的生长、巨噬细胞炎症因子IL-1β、IL-6、TNF-α表达和中性粒细胞的迁移抑制表皮炎症浸润,从而发挥抗炎作用。ELISA实验表明网络药理学发现白蓼花可能是通过槲皮素、山柰酚、芹菜素、异鼠李素、杨梅素等关键成分作用于TNF、Akt1、ALB、EGFR等核心靶点网络,进而通过PI3K-Akt和MAPK通路发挥抗炎疗效。
关键词:  网络药理学  白蓼花  炎症  酶联免疫吸附法  斑马鱼
DOI:10.13506/j.cnki.jpr.2026.06.003
基金项目:国家中医药管理局青年岐黄学者培养项目[No.(2022)256号]
收稿日期:2025-05-15   修回日期:2025-10-17  
Study on the anti-inflammatory mechanisms and active components of Koenigia coriaria(Grig.)T.M. Schust. based on UPLC-MS, network pharmacology, and zebrafish models
YAN Xiang1,2,JIA Liying1,2,LI Ruonan1,XUE Yan1,2,WANG Hong1,2,ZHAO Jingxia1,2,PENG Bing1,2
(1.Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China; 2. Beijing Institute of Traditional Chinese Medicine, Beijing 100010, China)
Abstract:
Objective There are currently no reports in the literature on the active components and anti-inflammatory effects of Koenigia coriaria(Grig.)T.M.Schust. This study aims to explore the anti-inflammatory active components and mechanisms of action of Koenigia coriaria(Grig.)T.M.Schust using ultra-performance liquid chromatography-mass spectrometry (UPLC-MS), zebrafish models, and in vitro experiments (RAW264.7 murine monocytic leukemia cell model) in a multidimensional manner. Methods Fresh Koenigia coriaria(Grig.)T.M.Schust were extracted to obtain the total extract of Koenigia coriaria(Grig.)T.M.Schust. The components of the total extract were identified using UPLC-MS. An in vitro lipopolysaccharide (LPS)-induced RAW264.7 macrophage model was established. The cell viability of macrophages treated with different concentrations of Koenigia coriaria(Grig.)T.M.Schust extract was detected by CCK-8 assay. The levels of inflammatory cytokines, including interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), secreted by macrophages treated with Polygonum lapathifolium extract were detected by enzyme-linked immunosorbent assay (ELISA). A zebrafish tail amputation-induced mechanical injury inflammation model was established, and the recruitment of neutrophils in zebrafish skin was observed using fluorescence microscopy to evaluate the effects of Koenigia coriaria(Grig.)T.M.Schust extract on the zebrafish inflammation model. Finally, the anti-inflammatory mechanisms of the active components of Koenigia coriaria(Grig.)T.M.Schust were predicted and analyzed using network pharmacology.Results UPLC-MS analysis identified 32 components in the total extract of Koenigia coriaria(Grig.)T.M.Schust, mainly including flavonoids and their derivatives, such as quercetin, rutin, kaempferol, and their glycosides, as well as phenolic acids, nucleosides, amino acids, terpenes, and organic acids. The cell experiment results showed that 6.25 μg·mL-1 Koenigia coriaria(Grig.)T.M.Schust extract significantly inhibited the growth of both normal macrophages and LPS-induced macrophages. After 24 hours of treatment Koenigia coriaria(Grig.)T.M.Schust extract, the expression levels of IL-1β, IL-6, and TNF-α in macrophages were significantly reduced (P<0.05, P<0.01, P<0.001). The zebrafish experiment results showed that compared with the normal control group, the number of neutrophils in the dorsal and ventral skin of zebrafish in the model group significantly increased (P< 0.001), showing obvious neutrophil migration. After treatment with Koenigia coriaria(Grig.)T.M.Schust extract, neutrophil migration was significantly inhibited in a dose-dependent manner. Conclusion The extract of Koenigia coriaria(Grig.)T.M.Schust exerts anti-inflammatory effects by inhibiting the growth of macrophages, the expression of inflammatory cytokines IL-1β, iIL-6, and TNF-αin macrophages, and the migration of neutrophils, thereby inhibiting epidermal inflammatory infiltration. The ELISA experiments, in conjunction with network pharmacology, suggest that Koenigia coriaria(Grig.)T.M. Schust may exert its anti-inflammatory effects through key components such as quercetin, kaempferol, apigenin, isorhamnetin, and myricetin, which act on core targets including TNF, Akt1, ALB, and EGFR, and through the PI3K-Akt and MAPK signaling pathways.
Key words:  Network pharmacology  Koenigia coriaria(Grig.)T.M. Schust.  Inflammation  ELISA  Zebrafish
今日访问量:2271    总访问量:55338612
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司